IL Biotechnology & Medical Research

Neurosense Therapeutics Ltd (NRSN)

Track

Neurosense Therapeutics Ltd saw two insider transactions in the last 90 days, both occurring on June 16, 2026. CEO Ben-Noon Alon and CFO Eisenberg Or each purchased $200,000 worth of shares, totaling $400,000 in buying activity. These transactions follow a period where the stock price declined by 47.7% over the last 90 days.
Ticker: NRSN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 16 Jun 2026
Value US$358,141.27 | Price 424.69 | Shares 67,984 (-42.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-16 B Purchase
Eisenberg Or

Chief Financial Officer

Officer
67,984 -42.2%
424.69
US$358,141 		67,984 -42.2% 424.69 US$358,141
2026-06-17 2026-06-16 B Purchase
Ben-Noon Alon

Chief Executive Officer

Officer
93,481 -14.5%
185.21
US$4,708,348 		93,481 -14.5% 185.21 US$4,708,348
Explore more

More insider trading research around Neurosense Therapeutics Ltd

More insider trades in IL
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity